Artigo Acesso aberto Revisado por pares

Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea

2022; American Society of Tropical Medicine and Hygiene; Volume: 106; Issue: 4 Linguagem: Inglês

10.4269/ajtmh.21-0713

ISSN

1476-1645

Autores

Mory Keïta, Mahamoud Sama Chérif, Billy Muyisa Sivahera, Samuel Boland, Freddy Banza-Mutoka, Mamadou Kourouma, Alseny Camara, Youssouf Sidibé, Jean Paul Kimenyi, Lamine Diassy, Angelo Loua, Ibrahima Sory Fofana, Youba Kandako, Dobo Onivogui, Enogo Koivogui, Tamba Jacques Millimono, Fode Bangaly Diakite, Mamadou Oury Baldé, Bienvenu Houndjo, Ngoy Nsenga, Ambrose Talisuna, Alexandre Délamou, Olivia Keiser, Georges Ki-Zerbo, Abdou Salam Guèye,

Tópico(s)

Hepatitis B Virus Studies

Resumo

In this case report, we describe a clinical presentation and therapeutic history of a unique case diagnosed with Lassa fever and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a 23-year-old man from Yomou prefecture in southeast Guinea identified with suspected Ebola Virus Disease (EVD) in the midst of an ongoing outbreak of that disease in the same region. On May 3, 2021, he was admitted to the Nzérékoré Epidemic disease treatment center where his clinical condition deteriorated significantly. Laboratory testing performed on the same day reveals a negative EVD polymerase chain reaction (PCR). Three days later, the patient was tested positive for SARS-CoV-2 and Lassa fever by reverse transcriptase PCR (RT-PCR) assays. Laboratory examination also indicated severe hematological and biochemical deteriorations in the patient. This case substantiates the need for systematic differential diagnosis during epidemic-prone disease outbreaks to better manage severely unwell patients.

Referência(s)